Periodic Reporting for period 1 - Biosafety (Biosafety assays for the diagnosis and prediction of drug-related complement pathology)

The safety issue addressed by our consortium refers is the frequest occurrence of allergic reactions, also known as infusion-, or hypersensitivity reactions (HSRs), to nanomedicines and most recently, COVID vaccines. These are complex, immune-mediated adverse effects that can...